Reteplase versus Alteplase for Acute Ischemic Stroke.
Shuya LiHong-Qiu GuHao LiXuechun WangAoming JinShuming GuoGuozhi LuFengyuan CheWeiwei WangYan WeiYilong WangZixiao LiXia MengXingquan ZhaoLiping LiuYong-Jun Wangnull nullPublished in: The New England journal of medicine (2024)
Among patients with ischemic stroke within 4.5 hours after symptom onset, reteplase was more likely to result in an excellent functional outcome than alteplase. (Funded by China Resources Angde Biotech Pharma and others; RAISE ClinicalTrials.gov number, NCT05295173.).